Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trialManish A. Shah, Rui‐Hua Xu, Peter C. Enzinger et al.|Nature Medicine|2023Cited by 541
Dietary and serum vitamins A and E and colorectal cancer risk in Chinese population: a case–control studyHong Luo, Cai‐Xia Zhang, Yu-Jing Fang et al.|European Journal of Cancer Prevention|2018Cited by 31